Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 10—October 2006
Research

Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children

Lisa A. Prosser*†Comments to Author , Carolyn Buxton Bridges‡, Timothy M. Uyeki‡, Virginia L. Hinrichsen*†, Martin I. Meltzer‡, Noelle-Angelique M. Molinari‡, Benjamin Schwartz‡, William W. Thompson‡, Keiji Fukuda‡, and Tracy A. Lieu*†§
Author affiliations: *Harvard Medical School, Boston, Massachusetts, USA; †Harvard Pilgrim Health Care, Boston, Massachusetts, USA; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA; §Children's Hospital, Boston, Massachusetts, USA

Main Article

Figure 3

One-way sensitivity analyses on selected variables for children ages 6–23 months not at high risk, in dollars per quality-adjusted life years gained. This figure reports variables to which the results were most sensitive. Variables not reported here had less effect on results than those included above. Base case=$12,300.

Figure 3. One-way sensitivity analyses on selected variables for children ages 6–23 months not at high risk, in dollars per quality-adjusted life years gained. This figure reports variables to which the results were most sensitive. Variables not reported here had less effect on results than those included above. Base case=$12,300.

Main Article

Page created: November 09, 2011
Page updated: November 09, 2011
Page reviewed: November 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external